共 23 条
Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain
被引:24
作者:
Llinàs-Brunet, M
Beaulieu, PL
Cameron, DR
Ferland, JM
Gauthier, J
Ghiro, E
Gillard, J
Gorys, V
Poirier, M
Rancourt, J
Wernic, D
机构:
[1] Boehringer Ingelheim Canada Ltd, BioMega Res Div, Laval, PQ H7S 2G5, Canada
[2] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
关键词:
D O I:
10.1021/jm980612i
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Src homology-2 (SH2) domains are noncatalytic motifs containing approximately 100 amino acid residues that are involved in intracellular signal transduction. The phosphotyrosine-containing tetrapeptide Ac-pYEEI binds to the SH2 domain of p.56(lck) (Lck) with an affinity of 0.1 mu M. Starting from Ac-pYEEI, we have designed potent antagonists of the Lck SH2 domain which are reduced in peptidic character and in which the three carboxyl groups have been eliminated. The two C-terminal amino acids (EI) have been replaced by benzylamine derivatives and the pY + 1 glutamic acid has been substituted with leucine. The best C-terminal fragment identified, (S)-1-(4-isopropylphenyl)ethylamine, binds to the Lck SH2 domain better than the C-terminal dipeptide EI. Molecular modeling suggests that the substituents at the 4-position of the phenyl ring occupy the pY + 3 lipophilic pocket in the SH2 domain originally occupied by the isoleucine side chain. This new series of phosphotyrosine-containing dipeptides binds to the Lck SH2 domain with potencies comparable to that of tetrapeptide 1.
引用
收藏
页码:722 / 729
页数:8
相关论文